First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine

Detalles Bibliográficos
Autores principales: Walsh, SR, Seaman, MS, Johnson, JA, Tucker, RP, Krause, KH, Weijtens, M, Pau, MG, Goudsmit, J, Dolin, R, Barouch, DH, Baden, LR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441301/
http://dx.doi.org/10.1186/1742-4690-9-S2-O52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441301/
http://dx.doi.org/10.1186/1742-4690-9-S2-O52

Ejemplares similares